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Abstract
Nicotine has been defined as a potent parasympathomimetic alkaloid that accumulates in the roots and leaves of Nightshade
family of plants. Aim: This study was aimed at evaluating the effects of orally ingested nicotine in the histology of hippocampus,
substantia nigra and cerebellum.
Materials and Methods: Twenty four adult male Wistar rats (100g - 200g) were randomly divided into 4 groups (group 1 -
group 4). Group 1 served as the control group, while groups 2 - 4 were the treated groups. Nicotine was diluted in water and
1ml of the different dosage (2mg/kg/day, 4mg/kg/day and 6mg/kg/day) were administered to the treated groups respectively
with the aid of orogastric cannula for 42 days. Animals were euthanized by cervical dislocation at the end of 7, 21 and 42
days so as to demonstrate the dose and time dependant effect of this agent. Brain tissues were harvested, processed and
stained using Haematoxylin and eosin according to standard histological techniques. Stained tissue images were captured
using digital micrometer eyepiece and cell count was determined using stereological technique.
Statistical analysis: Data obtained were subjected to statistical analysis with the use of statistical package for social
sciences (SPSS version 20). Significant differences were obtained using One Way Analysis of Variance with a probability of
0.05 (95% confidence limit) and Tukeys post hoc test was further used to determine the mean significant differences between
specific groups.
Results: Histological findings showed mild, moderate and severe hyperplasia in a dose and time dependant manner.
However, observations from quantitative analysisalso revealed a dose and time dependant significant increase in neuronal
cell count and cell diameter of the hippocampus, Substantia nigra and cerebellum.
Conclusion: This study has demonstrated that oral exposure of Nicotine in rats display proliferative adaptive changes on the
hippocampus, substantia nigra and cerebellum in a dose/time dependent manner.
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Introduction
Cigarette smoking has enormous negative health consequences
yet there has been a recorded increase in tobacco consump-
tion. [1] Although 4000 components of nicotine have been
described in cigarettes, nicotine is known as the most abundant
alkaloid in tobacco. [2, 3] Nicotine, a potent parasympath-
omimetic alkaloid has been shown to accumulate in the roots
and leaves of Nightshade family of plants where it constitutes
approximately 0.60 - 3.00% of the dry weight of tobacco.
This agent ranges between 2- 7 µg/kg of various edible plants
consumed through cigarette smoking and tobacco chewing
in 30.0 - 40.0% of the world’s population. [4] In Nigeria,
nicotine is an important constituent of cow urine concoction
(CUC) a local remedy used by the Yorubas for the treatment
of convulsion in children. [5] Nicotine has been shown to be
a natural ingredient in tobacco leaves used as an insecticide
in agriculture for pest control. [6]
It has been reported to be the major tobacco alkaloid oc-
curring to the extent of about 1.5% by weight in commercial
cigarette tobacco and comprising about 95% of the total alka-
loid content. [3, 7] Oral snuff and pipe tobacco also has been
demonstrated to contain concentrations of nicotine similar to
cigarette tobacco, whereas cigar and chewing tobacco con-
tributed only about half of the nicotine concentration of the
cigarette. [8, 9, 10] An average tobacco rod contains 10 to 14
mg of nicotine, [11] and on average about 1.00 to 1.50 mg of
nicotine is said to be absorbed systemically during smoking.
[3]
Nicotine uses and its benefits has been applied in medicine
in the treatment of nicotine dependence in order to eliminate
smoking. [12] Controlled levels of nicotine were administered
to patients in therapy through gums, dermal patches, lozenges,
electronic substitute cigarettes and nasal sprays. [12, 13]
The relevance of nicotine in health related diseases and as an
anti-herbivore chemical has also been reported. [14]
Nicotine from a smoked cigarette has been demonstrated
to be circulated to the brain in as little as 7 seconds after
inhalation. [15] A typical cigarette contains approximately
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0.50 to 1.00 g of tobacco and on average, 10 mg of nicotine,
[16] with cigarette smoking of about 10 puffs and within 5
minutes, a typical smoker would have absorbed 1.00 to 2.00
mg of nicotine. Absorption can however, range from 0.5 to
3 mg. [16, 17] The elimination half-life of nicotine is 2 to 3
hours; which implies a reduction in the blood level of nicotine
by half after a smoker tries to quit smoking for that particular
period. [17]
The addictiveness of nicotine was shown to be as a re-
sult of the continual use of tobacco product which resulted
in exposure to different carcinogens and other bioactive com-
pounds in tobacco, making tobacco use the leading cause of
premature death in developed countries. [18] Addiction to
tobacco kills one person prematurely every six seconds. [16]
One in two long-term smokers especially in low and middle
income countries will die from tobacco addiction. [16]
Matta (2007), [19] classified nicotine as both a stimulant
and a depressant based on its ability to cause release of Glu-
cose and epinephrine from the liver and adrenal medulla. As
a stimulant, it increases attention, memory, information pro-
cessing, and learning. [3, 19] Further studieshave suggested
that, when smokers desire a stimulating effect, they ingest or
inhale short quick puffs, which produces a low level of blood
nicotine and generation of action potential. [19] Alternatively,
when relaxation was desired, deep puffs are taken which pro-
duce a higher level of blood nicotine inhibiting nerve impulse
transmission and producing mild sedative effects. [19] At
low doses, nicotine potently enhances the actions of nore-
pinephrine and dopamine in the brain, which resulted in drug
effect psycho stimulation while at higher doses, nicotine is
said to enhance the effect of serotonin and opiate activity, pro-
ducing a calm, pain-killing effect. [20] It has also been shown
to alleviate anxiety, depression, and pain as such, smokers
labelled it a stress reliever and were vulnerable to smoke in
response to stressful situations or negative moods. [20]
Relationship between cigarette smoking and Parkinson
disease was observed by Morens et al. [21] several other in-
vestigators have reported a reduced risk of Parkinson disease
among smokers and have also provided a strong evidence
on the protective effects of smoking. [22, 23, 24, 25, 26]
Nevertheless, biochemical hypothesis of cigarette smoke com-
ponents, indicated neuroprotection and reduction of enzymatic
activity of type B monoamine oxidase in the brain. [27]
Tobacco exposure through the various forms of tobacco
consumption has been associated with negative effects on
body organ and systems alteration including the brain and
nervous system. [23, 26] Studies have suggested that nicotine
enhances protective mechanisms on the brain including nerve
growth factor deprivation, glutamate induced neurotoxicity
and alpha beta mediated cytotoxicity. [23, 26]
Jalili in 2009, carried out a study on morphometrical anal-
ysis of the effect of nicotine administration on brain prefrontal
region in male rats. [27] Nicotine was administered intraperi-
toneally for three days; this was to determine the effect of
nicotine on neuronal parameters such as neuronal processes,
dendritic spine and size of pericarion. The study showed a
decrease in the sizes of pericarions and a dose dependant
increase in dendritic spines of experimental animals. [27]
Similarly, another experimental and observational study
aimed at investigating the effects of prenatal exposure to nico-
tine on prefrontal cortex of the adolescent rats showed de-
rangement in biochemical profile of the prefrontal cortex in
all the experimental groups. [28] According to this study,
animals exposed to nicotine during 2nd and 3rd weeks of
intrauterine life showed morphological and histological alter-
ations in the prefrontal cortex. [28]
Nicotine has been recognized as a cerebellar toxin. [29]
Cerebellar dysfunctions have been linked to lots of neuronal
deficits which were believed to be caused by lots of toxins.
[29] This could possibly be as a result of the affinity of nico-
tine agonists to cerebellar nicotine which has been demon-
strated from embryonic stage through adult hood as has been
documented. [30. 31] Chen et al. in 2003, noted a decrease
in the number of purkinje cells in the cerebellar vermis on
chronic exposure to nicotine. [32]
A similar experimental study by Johnsen and Miller (1986),
on the oral effect of 5.00mg/d and 10.00mg/d of nicotine on
male Sprague dawley rats for 60 days reported significant loss
of white core of cerebellum. [33] Another similar study also
reported that chronic consumption of nicotine exacerbated
cerebellar ataxia, [34] and can transiently improve dysarthe-
ria, limb and truncal titubation. [31] This was contrary to a
study by Lokanadham et al. in 2015, [35] who posited that
intraperitoneal administration of nicotine resulted to preserva-
tion of the cortical layer and disruption of white core of the
cerebellum, Purkinje cell and granular cell layer of the cere-
bellum. [35] Consequently, a study by Mohammed and his
colleagues in 2006, revealed a decrease in purkinje neurons of
the cerebellum with an increase in glial fibrillary acidic pro-
tein in the white matter and granular layer of the cerebellum.
[36]
A cohort study titled exposure of rats to environmental to-
bacco smoke during cerebellar development alters behaviour
and perturbs mitochondrial energetics was carried out by
Brian et al in 2012. [37] Rats were exposed to daily envi-
ronmental tobacco smoke at 300.00µg/m3 and 100.00µg/m3
from post-natal day 8 to post-natal day 23. The results ob-
tained demonstrated increased locomotor response with signif-
icantly perturbed cerebellar mitochondrial subproteome. Also,
a dose dependent up regulation of aerobic process was ob-
served. They concluded that the cortical period of cerebellar
development was most likely to be affected in environmental
tobacco exposure leading to neurobehavioral alterations. [37]
Many pharmacological factors have been known to cause
nicotine addiction. The substantia Nigra which has been de-
scribed as a part of the midbrain dopaminergic systems has
received so much concern majorly because of its roles in re-
inforcement and learning and has been linked to Parkinson’s
disease. [38] Nicotine was proven to support mesostriatal
dopamine antagonists and was also demonstrated to activate
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the ventral tegmental area and substantia nigra neurons lead-
ing to the release of dopamine from the nucleus accumbens.
[39, 40]
According to Min et al. (2004), low levels of nicotine
comparable with those encountered in smokers not only in-
creased the firing rate of substantia nigra neuron and ventral
tegmental dopaminergic neuron invitro but also caused cells to
fire more irregularly. [41] They suggested mechanism for this
as reported by Min et al. (2004), was that these effects were
mediated by activation of nicotinic acetylcholine receptors
located both post and pre-synaptically. [41]
Studies have shown physiologically that nicotine levels in
the brain enhanced excitatory glutaminergic inputs to ventral
tegmental dopamine neurons by activating presynaptic α7
nAchRs. [42] A similar study stated that it was known to
modulate inhibitory inputs by activating non α7 nAchRs seen
in GABAergic cells, which decreased inhibition of postsy-
naptic dopaminergic neurons. [43] Chronic administration of
nicotine has been reported to facilitate release of dopamine
and locomotor responses which has been shown to be as a
result of up regulation of dopamine D2 receptors and led to
dopamine turnover. [44] However, a study aimed at analyzing
the electrophysiological cause and behavioral consequence
of dopaminergic cell loss in knock in mouse strain bearing
hypersensitivity nicotinic α4 receptor subunits demonstrated
that nicotinic AchRs might be amongst the genes responsi-
ble for extensive cell death in substantia nigra than in the
ventral tegmental area. [45] The study further hypothesized
that nicotine administration induced prolonged excitation of
dopaminergic neurons without any morphological change.
[45]
Evidence from a study has shown that nicotine improves
cognitive function. [46] This theory is related to stimulation
of neurotransmitter signals in areas controlling memory and
cognitive processes. Their efficacies as putative treatments are
highly imperative in impaired cognitive function experienced
by patients with Alzheimer’s disease. [46] Bergstrom et al.
(1996), reported increase in dendritic length of pyramidal
neuron and decrease in the size of pyramidal cells in fontal
medial cortex following nicotine administration in animals.
[47]
Abrous et al. (2002), determined the effect of self-admi-
nistration of nicotine on hippocampal plasticity. [48] This
study involved 180.00µg and 320.00µg doses of nicotine
which were administered intravenously. Their finding indi-
cated that nicotine had major effects on the hippocampus
where it caused a decrease in PSA - NCAM expression, down
regulation of neurogenesis and an increase in cell death by the
measure of the number of pyknotic cell degeneration. [48]
Charles in 2011, reported that nicotine was very essential
in learning and memory enhancement in experimental ani-
mals. [49] He also evaluated its roles in neural cell genesis
in the dentate gyrus of the hippocampal formation. Similarly,
Charles (2011), also demonstrated the acute and chronic ad-
ministration of nicotine on the metabolism of amyloid precur-
sor protein (APP). [49] The study revealed that administration
of nicotine influenced the APP metabolism in young rats. The
mechanisms which mediated these responses have not been
fully elucidated but appeared to depend upon simulation of
the nAChR and availability of intracellular free Ca2+. [49]
He concluded that the result provided some support for the
hypothesis that nicotinic receptor agonists may have some
value in slowing the progress of Alzheimer’s disease. [49]
A cohort study aimed at investigating some of the effects
of both ethanolic and smoke tobacco on the hippocampus in
which tobacco extracts were administered via oral and inhala-
tional route at 10.72µg, revealed more population of cells in
experimental animals compared to control. [50] They further
concluded that consumption of nicotine via either smoking or
chewing tobacco may lead to some level of neurohistoarchitec-
tural alterations, brain weight changes and neurobehavioural
disruption. [50]
Alim et al. (2012), reported that short term administra-
tion of low dose nicotine enhanced memory processes and
improved the oxidative stress status of the brain. [51] They
however stressed that nicotine may have contributed to the
neuroprotective effects of tobacco use in Parkinson disease.
[51]
A model of nicotinic replacement therapy during preg-
nancy and breastfeeding were used to assess the consequences
of chronic exposure of nicotine in cerebral neuroplasticity in
offspring. [52] Dawley rats exposed to nicotine throughout
prenatal and postnatal development displayed no significant
alteration in dentate gyrus neurogenesis. Contrary to this
findings were that long term potentiation of nicotine led to a
significant increase in dentate gyrus. [52]
A study on the hippocampal and striatal histomorphology
following chronic nicotine administration in male and female
rats was carried out by Ijomone et al. in 2015. [53] Nicotine
was administered at a dose of 0.25, 2.00 and 4.00µg/kg for 28
days. This study showed a significant increase in percentage
of neurons with degenerative features in hippocampus and
striatum of both male and female rats. [54]
Studies have x-rayed in details the deleterious effects of
smoking and nicotine on the brain, liver, lungs, kidney, ovary
and testicular histology. [54, 55, 56, 57] Scanty literatures
have been specifically devoted to the evaluation of nicotine
on histology and quantitative analysis of the Cerebellum, Hip-
pocampus and substantia Nigra. [56, 58] Hence this research
was aimed at evaluating the impact of orally ingested nicotine
on the histology and cell count analysis of the Cerebellum,
Hippocampus and substantia Nigra. These selected parts of
the brain have been demonstrated to contain different forms
of nicotinic receptors, forms a major part of the mesolimbic
system and are directly or indirectly involved in the control of
movement.
1. Materials and Methods
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1.1 Animal and diet
Adult male Wistar rats with an average body weight of 100g -
200g were purchased from animal house of Delta State Uni-
versity Abraka. All animals were fed with commercially
formulated rat chowand water.
1.2 Chemical compound
The experimental drug was nicotine ((S) -3- (1-Methyl-2-
pyrroli- dinyl) pyridine).25.0g of nicotine hydrogen salt tar-
trate [ (95% nicotine); Sigma life science, 614-002-00-x
United Kingdom (batch number: USAB313 0016, Expiry
date: November, 2020) ] was purchased from Rovet Scientific
shop in Benin-City, Edo State, Nigeria.
1.3 Ethical consideration
Approval for this study was obtained from the Faculty of Basic
Medical Science ethical committee Delta State University
Abraka. This conforms to the guidelines for animal researches
stated by Animal research ethics in 2009. [59]
1.4 Sample size
This was determined using the resource equation E = Total
number of animals - Total number of groups. [60. 61]
Where E is the degree of freedom for the analysis of
variance. [60]
A total number of 24 male adult Wistar rats were used for
this study.
1.5 Study design
This was an experimental and observational study that entailed
four groups (1 - 4). The rats were weighed, sorted and as-
signed to a group containing four rats each. Animals were fed
with commercially formulated rat chow and water ad libithium
under standard condition (12 hours light and 12 hours dark-
ness, temp: 28-31◦C; humidity: 50-55%) and were allowed
to acclimate for two days before administration according
to animal acclimatization guidelines stated by Obernier and
Baldwin (2008); Animal research ethics (2009). [59, 62] The
experiment lasted for 6 weeks with animals euthanized at day
7, 21 and day 42; this was to demonstrate the time and dose
dependent effect of the agent.
1.6 Dosage and drug administration
Diluent for the administration of nicotine used was water and
time of administration was twice daily (6.00 am and 6.00pm);
this was to maintain a steady concentration of nicotine in
blood circulation Route of administration of test drug was oral
with the use of orogastric tube and experimental animals were
treated as indicated in (table 1).
The LD50 for oral nicotine administration in adult male
rats is 50mg. [3]
1.7 Inclusion and Exclusion criteria
The same species of rats and rats with similar body size were
used for this study. Rats with open wounds, other signs of
illness or injury and rats with physical signs of oedema were
excluded from this research. [63]
1.8 Animal euthanasia
Experimental rats were euthanized at 7, 21 day and 42 day by
cervical dislocation after an overnight fast. [64] Brain tissues
were harvested and fixed in bouin’s fluid. [65]
1.9 Histological procedures
Tissues from the substantia nigra, hippocampus and cerebel-
lum were processed and stained using standard histological
technique. [65]
1.10 Stereological analysis
Neuronal cell counts and cell diameters were determined by
taking the mean of cells sampled in a grid, using a Micro-
scope at a magnification of x100 which had an image analyzer
powered to a computer. [66]
1.11 Statistical analysis
Results of cells dimension were expressed as mean ± SEM.
Data were subjected to SPSS (Version 20), and were analyzed
using one way ANOVA at a confidence level of 95.0% which
was used to test differences between the means of the parame-
ters in the experimental groups. Levels of significance were
determined at (P < 0.05) and Tukey Post Hoc test was fur-
ther used to determine the significant differences between the
means of specific groups.
1.12 Photomicrography
Haematoxylin and Eosin Stained tissue images were captured
using digital microscopic eyepiece ”SCOPETEK” DCM 500,
5.0 mega pixel connected to computer
2. Results
Figure 1 showed the cerebellar cortex made up of molecu-
lar layer, purkinje layer and granular layer. The molecular
layer (ML) was composed of neurons with basophilic nuclei
peripherally located. The Purkinje cells in the Purkinje layer
(PL) were seen with a granulated eosinophilic cytoplasm and a
lightly stained round to oval granulated centrally placed nuclei.
Abundant neuronal nuclei disposed in clusters and granulated
in appearance were seen in the granular layer (GL). The cell
membrane appeared indistinct. Features revealed mild, mod-
erate and severe hyperplasia of the cerebellar cortex across
group with increase in dose and duration of exposure Fig-
ure 2 showed the Substantia nigra cytoarchitectural features
of experimental animals made up of numerous pigmented
multipolar neuronal cell bodies, axons and dendrites. The
pigmented neuronal cytoplasm was eosinophilic. The nuclei
were granulated, round to oval in shape with a non-prominent
nucleoli peripherally placed embedded in an indistinct cell
membrane. Also seen were abundant oligodendrocytes with
a centrally placed nuclei and pericytoplasmic hallow. These
features displayed mild, moderate and severe hyperplasia in a
dose and time dependant manner. Histological sections in fig-
ure 3 showed the layers of cornus ammonis (CA) and dentate
gyrus (DG). The polymorphic layer (PL) was made up of few
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Table 1. Experimental groups and Nicotine administration
Groups Designation Duration and TreatmentsSub-acute (7 days) Acute (21 days) Chronic (42 days)
1 Control Distilled water
2 Low dose 2mg/kg body weight of nicotine
3 Moderate dose 4mg/kg body weight of nicotine
4 Chronic dose 6mg/kg body weight of nicotine
Figure 1. Histological effects of Nicotine on the cerebellum of control and experimental rats exposed to different doses of
nicotine for 7, 21 and 42 days. H & E (x400)
Keywords: WM: White mater; arrow head (→ ): Purkinje cells; ML: Molecular layer; GL: Granular layer.
neurons. Next to this layer was the thick granular layer (GL)
which was made up of abundant granular cells with deeply ba-
sophilic nuclei centrally located occupying almost the whole
cytoplasm. The stratum oriens was made up abundant of
pyramidal cell fibres (SO). Next to the stratum oriens was
the stratum pyramidale layer (SP) which was composed of
abundant pyramidal cell. The pyramidal cells had triangular
shaped cell bodies with large, round to oval nucleus centrally
placed. The nuclear cytoplasmic ratio was 3:4 and the nu-
cleoplasm was composed of dense chromatin granules. Also
seen were abundant oligodendrocytes with centrally placed
nucleus and pericytoplasmic hallow. Features indicated mild,
moderate and severe hyperplasia of the hippocampus with
Gliosis.
Stereology result in table 2 above showed a significant
(P=0.00) increase in the cell count of the molecular, purkinje
and granular neurons across the group. Following the cell
count, severe hyperplasia was prevalent in group four (4)
which received the highest dose (6mg/kg body weight) of the
test drug. This notable change in the quantitative analysis in
the fourth group was significant (P =0.00) and was time and
dosage dependent.
From table 3 above, rats administered 2mg/kg body weight
of nicotine showed a significant transient (P=0.000) increase
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Figure 2. Histological effects of Nicotine on the Substantia nigra of control and experimental rats exposed to different doses
of nicotine for 7, 21 and 42 days. H & E (x400)
Keywords: Arrow head: pigmented neurons of the Substantia nigra; Arrow: Oligodendrocytes.
Table 2. Histomorphologic effects of nicotine on cerebellar cortex neuronal count from animals sacrificed on day seven (7)
Doses administered Molecular layer(µm) Purkinje layer(µm) Granular Layer(µm)
0mg/kg body weight 4.28±0.43a 1.45±0.15a 43.81±4.56a
2mg/kg body weight 6.18±0.51b 2.00±0.26a 53.08±5.99b
4mg/kg body weight 8.12±0.77b 2.35±0.29a 64.36±5.91a
6mg/kg body weight 8.51±0.65b 2.89±0.39a 80.89±5.81b
Notes: Values are expressed as Mean ± SEM for n = 4 rats. Values that bear another superscript on a column differ significantly (P<0.05).
(Source; Field work)
Table 3. Histomorphologic effects of nicotine on cerebellar cortex neuronal count from animals sacrificed on day twenty one
(21)
Doses administered Molecular layer(µm) Purkinje layer(µm) Granular layer(µm)
0mg/kg body weight 5.36±0.35a 2.00±0.37a 57.47±4.78a
2mg/kg body weight 10.91±1.21b 2.31±0.32b 78.10±5.89b
4mg/kg body weight 7.66±0.84b 2.06±0.21a 72.63±4.49a
6mg/kg body weight 9.16±0.82b 2.35±0.32b 78.50±4.05b
Notes: Values are expressed as Mean ± SEM for n = 4 rats. Values that bear another superscript on a column differ significantly (P<0.05).
(Source; Field work).
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Figure 3. Histological effects of Nicotine on the Cornus ammonis and Dentate gyrus of control and experimental rats exposed
to different doses of nicotine for 7, 21 and 42 days. H & E (x400)
Keywords: DG: Dentate gyrus; CA: Cornus ammonis; SO: Stratum oriens; SP: Stratum pyramidale; SR: Stratum radiatum; ML: Molecular
layer; GL: Granular layer; PL: Polymorphic layer; Arrow: Oligodendrocyte.
in both molecular and granular neurons with a non-significant
(P = 0.809) increase in the Purkinje layer on exposure to
nicotine. Test animals administered 4mg/kg body weight of
nicotine showed a non-significant increase in the cell count in
all the three layers. However, similar significant (P<0.001)
changes between rats administered 2mg/kg body weight of
nicotine and rats administered 6mg/kg body weight of nicotine
were also noted with a slight increase from 7.66±0.84 in
group three (3) to 9.16±0.82 in molecular layer of the group
that was administered 6mg/kg body weight of nicotine test
animals.
Results from table 4 above indicated hyperplasia of the
three layers of the cerebellar cell count on administration
of nicotine. Subsequent administration of nicotine with in-
creased time and dosage showed a significant (P = 0.000)
increase in the test groups cerebellar cortex as compared to
the control group. Severe hyperplasia was evident in the group
that was administered 4mg/kg body weight of nicotine which
received highest dose of the test drug and caused a significant
(P<0.000) change in the neurons across the group. An excep-
tion to this is in the Purkinje layer of group 3 rats that was
administered 4mg/kg body weight of nicotine showed a no
significant increase in the Purkinje neurons on exposure to
nicotine (P>0.05).
The experimental groups all showed significant increase
(P=0.00) in the quantitative analysis of the histology of the
substantia nigra when compared to control with increased
duration and dosage across the groups. Maximum signifi-
cant increase (P=0.00) were noted in group two test animals
(2mg/kg body weight) of day twenty one (21), group four test
animals (6mg/kg body weight) of day twenty one (21) and
day forty two (42).
Result from table 6 showed that the mean cell count of
the granular layer increased rapidly in the experimental rats
treated with nicotine for seven (7) and twenty one (21) days.
This statistical significant (p=0.002) changes is however ev-
ident in groups 2 (2mg/kg body weight), 3 (4mg/kg body
weight) and 4 (6mg/kg body weight) in 7 days and group 2
(2mg/kg body weight) and 4 (6mg/kg body weight) in 21 days.
Animals treated for 42 days also showed increases in granular
cells which was not significant in all the groups (P>0.00).
The result in table 7 above shows a significant (P=0.00)
increase in the cell count of the pyramidal neurons across
the group. Following the cell count, severe hyperplasia was
Histomorphological Effects of Nicotine on Selected Parts of the Brain of Adult Wistar Rats — 8/19
Table 4. Histomorphologic effects of nicotine on cerebellar cortex neuronal count from animals sacrificed on day forty two
(42)
Doses administered Molecular layer(µm) Purkinje layer(µm) Granular layer(µm)
0mg/kg body weight 5.43±0.35a 1.75±0.19a 56.46±4.58a
2mg/kg body weight 8.30±0.63b 2.30±0.26b 61.51±4.84b
4mg/kg body weight 7.57±0.82b 2.87±0.31a 67.50±2.34b
6mg/kg body weight 14.1±1.5b 4.00±0.67b 117.14±7.47b
Notes: Values are expressed as Mean ± SEM for n = 4 rats. Values that bear another superscript on a column differ significantly (P<0.05).
(Source; Field work).
Table 5. Histomorphologic effects of nicotine on Substantia Nigra dopamine producing neuronal count from animals
sacrificed on day 7, 21 and 42
Doses administered Day seven(µm) Day twenty one(µm) Day forty two(µm)
0mg/kg body weight 3.29±0.31a 2.00±0.16a 3.48±0.20a
2mg/kg body weight 5.58±0.64b 3.83±0.25b 4.02±0.22b
4mg/kg body weight 6.55±0.32b 7.12±0.44b 6.14±0.22b
6mg/kg body weight 7.12±0.37b 8.94±0.51b 8.90±0.42b
Notes: Values are expressed as Mean ± SEM for n = 4 rats. Values that bear another superscript on a column differ significantly (P<0.05).
(Source; Field work).
Table 6. Histomorphologic effects of nicotine granular neuronal count of the dentate gyrus from animals sacrificed on day
seven, day twenty one and forty two
Doses administered Day seven(µm) Day twenty one(µm) Day forty two(µm)
0mg/kg body weight 18.44±1.96a 29.44±3.74a 35.29±2.47a
2mg/kg body weight 20.21±2.32b 38.38±3.22b 37.5±3.56a
4mg/kg body weight 48.00±5.79b 47.47±4.18a 42.27±2.82a
6mg/kg body weight 51.42±7.35b 58.00±5.85b 46.60±2.97a
Notes: Values are expressed as Mean ± SEM for n = 4 rats. Values that bear another superscript on a column differ significantly (P<0.05).
(Source; Field work).
Table 7. Histomorphologic effects of nicotine pyramidal neuronal count of the cornus ammonis from animals sacrificed on
day 7, day twenty one and forty two
Doses administered Day seven(µm) Day twenty one(µm) Day forty two(µm)
0mg/kg body weight 3.38±0.60a 8.09±0.96a 12.00±0.86a
2mg/kg body weight 6.58±0.92b 12.63±1.19a 15.83±1.89a
4mg/kg body weight 8.85±1.27b 14.00±1.39a 16.54±1.13b
6mg/kg body weight 11.90±3.57b 18.92±1.84a 22.61±1.81b
Notes: Values are expressed as Mean ± SEM for n = 4 rats. Values that bear another superscript on a column differ significantly (P<0.05).
(Source; Field work).
prevalent in group four (6mg/kg body weight) with increase
duration of nicotine. This notable change in the quantitative
analysis in the fourth group that received 6mg/kg body weight
of nicotine is significant (P=0.00) and is seen in group 2
(2mg/kg body weight), 3 (4mg/kg body weight) and 4 (6mg/kg
body weight) in day seven and twenty one. However, a similar
increase which was (P=0.05) also seen in group 3 (4mg/kg
body weight) animals exposed to test drug for a period of 42
days.
Table 8 shows that the maximum diameter of the dopamine
producing neuron of the Substantia nigra is seen in group four
(6mg/kg body weight) treated for 21 days. Cell count in-
creases were apparent between day seven and day twenty
one treated animals which is not significant. Comparing neu-
ronal diameter of day forty two animals to the twenty one
test animals showed a slight significant decrease in test ani-
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Table 8. Effect of nicotine on dopamine producing neuron diameter from animals sacrificed on day 7, day twenty one and
forty two
Doses administered Day seven(µm) Day twenty one(µm) Day forty two(µm)
0mg/kg body weight 34.85±1.77a 88.72±7.86a 53.79±2.09a
2mg/kg body weight 41.02±6.11a 94.39±7.72a 76.18±9.47a
4mg/kg body weight 55.95±11.82a 86.47±1.77a 82.07±4.18b
6mg/kg body weight 59.73±2.33a 103.14±7.19a 84.70±2.50b
Notes: Values are expressed as Mean ± SEM for n = 4 rats. Values that bear another superscript on a column differ significantly (P<0.05).
(Source; Field work).
mals administered nicotine for forty two days. Statistically
significant groups (p= 0.02) were seen in group 3 (4mg/kg
body weight) and group 4 (6mg/kg body weight) test animals
sacrificed on day forty two.
The result in table 9 above shows a significant (P=0.002)
increase in the diameter of the Purkinje neurons across the
group. Following the cell count, severe hyperplasia was preva-
lent in group four (6mg/kg body weight) with increase du-
ration of nicotine. Maximum significant diameter is seen in
group 4 (6mg/kg body weight) of animals exposed to nicotine
for twenty one days, with a very slight significant decline
between this group and group four (6mg/kg body weight) of
animals treated for forty two days.
Results in table 10 showed animals exposed to test drugs
for seven days showed a statistical significant increase in
pyramidal cell diameter across the group. With subsequent
administration of nicotine for twenty one and forty two days,
there was a non-significant (P= 0.068) increase in pyrami-
dal cell diameter between animals administered nicotine for
twenty one days and forty days respectively.
3. Discussion
The present study examined the histomorphological, varying
dose/time effects of nicotine in the hippocampus, cerebellum
and substantia Nigra. Several studies on neuronal interactions
of nicotine have highlighted the adverse and beneficial po-
tentials of this agent on the brain and thus, have raised many
controversies. [22, 23, 24, 25] However, judging from the
scientific investigations conducted on the clinical significance
of nicotine, it has become paradoxical to note that studies that
employed the use of histological, stereological and statisti-
cal tools in exploring the neuronal responses to these agents
have been few while available ones did not employ the use of
statistical tools as a basis for their arguments. [67]
This index study clearly demonstrated hyperplasia in cell
population and hypertrophy. Hypertrophy has been described
as physiological response to a specific stimulus that results
to an increase in the amount of organic tissue that results
from proliferation. [68] Hyperplasia has been described as
an adaptive response in replicating cells and in cells induced
to replicate by an introduction of an agent. Hypertrophy and
hyperplasia may occur independently but in some cases, they
can occur together as demonstrated from findings of this study.
[68]
3.1 Histological changes in the cerebellum
Cerebellar areas have been reported to be imperative in inte-
gration and regulation of well-coordinated muscular activities,
regulation of tone, posture and equilibrium by regulating im-
pulses from tactile, proprioception, visual and auditory recep-
tors. [69] The cerebellar hemisphere is the major channel that
connects sensory areas of the brain to motor areas of the brain.
It forms a relationship during coordinated movement which is
involved in motor learning and modifications of reflexes. [31]
The cerebellum has been reported to be susceptible to toxic
chemical compounds and drugs at higher doses; granular layer
and Purkinje neurons are usually more vulnerable compared
to the molecular layer which is least affected. [70] Amongst
the cerebellar toxins as described by Manto, [70] low dose of
nicotine was shown to be neuro-protective in the cerebellum.
[27]
The current study demonstrated that oral administration of
nicotine for seven days resulted in mild hyperplasia compared
to experimental rats exposed to nicotine for 21 and 42 days.
Findings from the molecular layer of the cerebellum showed
preserved histoarchitetural and cytoarchitectural features of a
viable neuron with increased proliferation of neuronal cells.
These however, suggested a proliferative effect of nicotine and
could be as a result of the low dosage and short duration of ex-
posure to nicotine but disagrees with findings by Lokanadham
et al, who reported neuronal degeneration in the cerebellum.
[35] Reasons for the dissimilarity could be the longer duration
and higher dosage of nicotine administration to test animals.
Further studies should employ the use of histochemical stains
such as cresyl violet to demonstrate the viability of neurons
in the cerebellar layers.
Purkinje neurons exhibited well preserved and non-distorted
neuronal characteristics with a transient increase in the Purk-
inje cell number which was suggestive of mild hyperplasia.
This finding is contrary to a study conducted by Omtosho
and Babalola (2014), who observed a degree of shrinkage in
animals exposed to cigarette smoke. [28] Differences in obser-
vation could be that cigarette smoke has been demonstrated
to contain several active components which have been demon-
strated to work synergistically to produce neurodegeneration
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Table 9. Effect of nicotine on purkinje cells diameter from animals sacrificed on day 7, day twenty one and forty two
Doses administered Day seven (µm) Day twenty one (µm) Day forty two (µm)
0mg/kg body weight 55.50±2.25a 62.00±4.51a 49.39±3.04a
2mg/kg body weight 55.70±2.02b 78.00±1.52a 61.86±4.47a
4mg/kg body weight 66.00±2.30a 81.90±0.58a 70.87±2.23a
6mg/kg body weight 72.66±6.35b 87.25±7.20a 87.07±6.48a
Notes: Values are expressed as Mean ± SEM for n = 4 rats. Values that bear another superscript on a column differ significantly (P<0.05).
(Source; Field work).
Table 10. Effect of nicotine on pyramidal cells diameter from animals sacrificed on day 7, day twenty one and forty two
Doses administered Day seven Day twenty one Day forty two
0mg/kg body weight 70.85±0.88a 64.69±3.99a 76.32±5.60a
2mg/kg body weight 75.4±0.78b 88.84±10.05a 88.05±3.00a
4mg/kg body weight 84.93±1.88a 80.53±2.40a 93.67±9.66a
6mg/kg body weight 95.22±6.27b 85.78±1.79a 102.46±0.63a
Notes: Values are expressed as Mean ± SEM for n = 4 rats. Values that bear another superscript on a column differ significantly (P<0.05).
(Source; Field work).
of Purkinje cells previously documented. [3, 28] However,
for further studies, phytochemical screening of cigarettes and
tobacco should be employed; so as to separate the active in-
gredients in cigarette and the individual components should
be tested on experimental animals to indicate the specific
components that produce the observable effect.
The granular layer of the cerebellum on exposure to nico-
tine for seven days showed brain parenchyma preservation,
and increase in cellularity. The increase in cellularity of the
granular layer neurons is suggestive of mild hyperplasia as
compared to other groups. These findings disagrees with a
study conducted by Lokanadham et al. in 2015, [35] who
concluded that long term exposure of nicotine results to loss
in cellularity of the granular layer. Dissimilarity in the find-
ing with that of the current study could be as a result of the
route of nicotine administration. The latter study adminis-
tered nicotine intraperitoneally which is similar to intravenous
route and releases a large concentration of nicotine to blood
concentration as compared to oral route which is extensively
metabolized in the liver and cleared in the kidney. [71, 72]
Other routes of drug administration can also be employed
so as to compare the various effects produced on nicotine
administration.
The molecular layers of the animals administered nicotine
for 21 days, showed increase in cellularity as compared to
experimental animals administered nicotine for 7 days with
absence of morphological alterations. This neuronal prolif-
eration could be attributed to the neuro-protective effect of
nicotine, and the small dosage of nicotine administration. This
agrees with the inference that low doses of nicotine poses a
stimulating effect on the central nervous system. [3, 19, 26]
The reason for this is likely due to the fact that the molecular
layer is least susceptible to chemical toxins and drugs. [70]
On administration of nicotine for twenty one days, the
purkinje cells showed increase in cellularity suggestive of
moderate hyperplasia as compared to other groups. This Purk-
inje cells histoarchitectural and cytoarchitectural cellularity
is contrary to a study which demonstrated disruption of the
Purkinje cell. [35] Reasons for this dissimilarity between
the present study and that of Lokanadham and his colleagues
could be ascribed to intraperitoneal route of nicotine adminis-
tration and difference in nicotine dosage employed in the two
studies. However, a future study should involve another means
of drug administration such as inhalational route which has
been reported as the fastest route for nicotine administration.
[73]
The deep granular cell layer of the cortex maintained its
histological characteristics but with a dose dependant increase
in the granular neuron which also suggests moderate hyper-
plasia without morphologic disruption. This observation does
not concur with findings from a study by Lokanadham et al.
(2015), who discovered granular cell disruption that could in-
variably lead to cerebellar disorders such as cerebellar ataxia
that can transiently improve dysartheria as reported by Tewari
(2010) and Houk et al. (1993). [31, 34] Possible reasons for
the observed differences could be attributed to differences
in nicotine metabolism and renal clearance between the two
different routes of administration in the study; but however,
further studies should be carried out on the toxicological anal-
ysis of nicotine to buttress this finding.
A dose dependant severe hyperplastic change was seen in
the cerebellar molecular layer of rats exposed to nicotine for
the long duration of exposure. This finding is in agreement
with the finding that chronic administration of nicotine for 42
days maintains the cerebellar histological characteristics and
does not induce neuronal impairment as previously reported.
[29]
The Purkinje cells play an important role in development
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and maturation of the cerebellum. [74] It has been reported to
exert an inductive effect on the development of the cerebellar
granule layer; and also is the most likely vulnerable layer
susceptible to toxins. [70, 74] The Purkinje cell showed no
neurodegeneration with an increase in duration of exposure
but rather a marked and dose dependant increase in cellular-
ity which suggests severe hyperplasia as compared to other
groups. This finding is contrary to a study conducted by
Mohammed et al. (2006), who reported Purkinje cell degener-
ation on chronic and long term exposure to nicotine. [36] The
reason for this might be attributed to the in-utero exposure
of nicotine during the embryonic period of development in
Mohammed’s study. The embryonic period of development
has often been described as the most critical and sensitive
time of induction of birth defects. [75] Further studies should
however consider administration of nicotine in-utero but dur-
ing the fetal period; as it is a period with reduced risk of gross
structural abnormalities
Granular cells accounts majorly for most of the neurons in
the human brain and hence, play a vital role in determination
of Cerebellar functions. [76] The deep granular layer on expo-
sure to nicotine indicated a similar resultant pattern as in day
seven and day twenty one but with severe hyperplasia. This
observation could be explained by the mechanism of action
of nicotine or its antioxidant effects as previously reported
by Imosemi, et al. in 2013. [77] Receptors in the granular
layer includes glutamate receptors, nicotinic and muscarinic
receptors; nicotine has been proven to enhance excitatory glu-
taminergic inputs by activating presynaptic α7nAchRs. [42,
78] The present study did not provide a molecular basis for
this observation and may be considered in future investiga-
tions.
3.2 Quantitative changes in the cerebellum
The present study demonstrated a dose dependant significant
increase (P < 0.05) in neuronal count of the molecular layer
of rats exposed to nicotine for seven days. This finding has
been related to the fact that the molecular layer is the least of
the cerebellar layers to be affected by chemical compounds
as noted by Fonum and lock in 2000. [74] This hypothetical
analysis did not concur with the report of Tewari in 2010 who
explained molecular hypoplasia following long term adminis-
tration of nicotine. [31]
Purkinje cells morphology have been frequently reported
using both quantitative and qualitative methods. [79, 80]
Purkinje cell count revealed a significant increase in Purkinje
cells especially in the group that received the highest dose of
nicotine for seven days. Result from Purkinje cell diameter
further showed a dose dependant significant increase in the
diameter of the cell membrane. These observations strongly
provided evidence on the hyperplastic and hypertrophic ac-
tivity of nicotine and do not agree with findings by Chen et
al, (2003), [32] who reported decrease in Purkinje cells. Pos-
sible reasons for the result differences could be the fact that
Chen did not employ any stereological technique and rather
based his findings on observations which did not provide any
statistical basis for hypothetical testing. For further studies,
the Cavialieri’s principle should be used in the cell count be-
cause it expresses volume number connectivity and the linear
biological structures are expressed as absolute values. [81]
Quantitative analysis of the granular layer revealed a dose
dependant significant increase in granular layer cell count;
however, Omotosho and Babalola (2014), [67] reported re-
duction of granular cell number. Reasons for this disparity
account to the different route of drug administration used
by Omotosho and Babalola who also based his quantitative
analysis on mere observations without the use of stereolog-
ical grid counting techniques and hence his findings lacked
hypothetical deductions. They results from the quantitative
analysis therefore implied that nicotine exerted hyperplasic
and hypertrophic effect on the cerebellum
The molecular layer showed an increase in cell count,
which was coupled with a simultaneous increase in the cell
layers. This significant increase was very apparent in group 2
and group 4 and is suggestive of mild to moderate hyperplasia
of this layer; however, the study by Tewari and his colleagues
in 2010, [31] reported a significant loss in central core and
molecular layer of the cerebellum. The existing controversies
in this finding could be a result of an aluminium foil which
was covered with the nicotine containing cannula used in the
study by Tewari et al. 2010. Aluminium has been demon-
strated to be a powerful toxin in nervous system embryology.
[82] Similar observations were noted on exposure of nicotine
to experimental animals, a dose dependant increase (P > 0.05)
in Purkinje cell proliferation and a significant dose dependent
increase in Purkinje cell diameter was recorded. The findings
in the purkinje layer could be related to the neuro-behavioral
state of the animals such as depression which has been re-
ported to affect growth of neurons. [83] However, for further
studies nicotine administration should be examined together
with neurobehavioral studies so as to correlate the observable
differences.
The administration of nicotine to experimental rats in-
creased the number of neuronal cells of the granular layer.
This increase suggests a moderate hyperplastic effect of nico-
tine. Moderate hyperplasia was present with an average num-
ber of cells in viable neurons present within this layer. This
result could be as a result of the mechanism of action of
nicotine on the nAChRs in the granular layer.
With increased duration and exposure of nicotine, the
molecular layer showed a dose dependant significant severe
hyperplasia down the group (P < 0.052). This finding could
be as a result of the possible positive interactions between the
nAChRs in the brain and nicotinic agonist such as nicotine.
The extensive severe hyperplasia of Purkinje cell was very
evident and significant with increase in dosage and exposure
of experimental animals to nicotine. Purkinje neurons which
have been reported to be very vulnerable to chemical com-
pounds in the brain also showed marked and dose dependent
increase in Purkinje cell diameter. This observation further hy-
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pothesizes the moderate hyperplastic and hypertrophic effect
of nicotine.
Quantitative analysis of the granular neurons showed a
dose dependant significant increase in cell count. This in-
crease was very significant across and within the groups. It
further infers that nicotine agonists (nicotine) exert a severe
hyperplastic effect on the granular neurons. This observable
increased cellularity could be explained with the longer pe-
riod of nicotine exposure to model animals and has not been
previously reported.
The cerebellar circuit is made up of climbing fibers, mossy
fibres and parallel fibres and they are all excitatory and may
probably use L- glutamate as neurotransmitter. [78] Purkinje
cells have been shown to be made up of GABA while recep-
tors in granular layer mediating glutaminergic and choliner-
gic transmissions include ionotropic (glutamate receptors of
NMDA (N- Methyl - D- aspartate) and Non NMDA type A
metabotropic (coupled to 2nd messengers systems), Glutamate
receptors, Nicotinic and muscarinic acetylcholine receptors.
[78] Mansvelder (2002), [42] reported that nicotine is known
to modulate inhibitory inputs by activating non α7 nAchRs
seen in GABAergic cells, which decreases inhibition to post-
synaptic neurons.This might be a likely mechanism for the
neuroprotective effect exerted by nicotine in the cerebellum.
3.3 Histological Changes in the Substantia Nigra
The substantia nigra is highly essential in the control of fine
motor movement. [84] Many of its cells have been shown
to contain neuromelanin and its cells give rise to nigrostri-
atal fibres which are dopaminergic and appear to act as a
neurotransmitter causing inhibitory effects particularly on
neurons in the corpus striatum. [84] Loss of about 80% of its
dopamininergic cells is a fundamental defect in Parkinsonism.
[84]
This study showed that experimental animals, adminis-
tered nicotine for seven days were presented with no mor-
phological alterations and neurodegeneration and mild hy-
perplastic changes were observed in the tissue architecture
which indicated that with administration of nicotine, there
was a dose dependant increase in cellularity in all the groups
treated with nicotine. Mild hyperplasia has been shown to be
a neuronal physiologic response characterized by little or few
increase in cell number. [68] This observable change in the
substantia nigra could be linked to the neurogenesis potentials
of nicotine reported by Eriksson et al. in 1998. [85] Neuronal
growth and generations from progenitor cells have also been
demonstrated in rats’ substantia nigra. [86] However, further
studies should investigate the neurogenesis potentials on areas
of the brain using biomarkers or antigens specific for nerve
growth factor which is responsible for neuron generation.
In the current study, mild to moderate hyperplasia was
observed in substantia nigra of animals exposed to nicotine
for twenty one days. These mild to moderate proliferation
of pigmented neurons increased as treatment continued with
varying doses. The resultant pattern revealed the proliferative
effect of nicotine. This activity of nicotine was further but-
tressed with the fact that nicotine induced development of new
neuronal cell line and thus suggests neurogenesis potentials
observed in animals treated for twenty one days. This could
be linked to the stimulating effect of nicotine; where nicotine,
acted on neurons and improved cellularity in certain regions
of the brains. [3, 19]
The present study indicated that nicotine exerted a severe
hyperplastic effect on pigmented neuron of the substantia
nigra. Nicotine also conferred an improvement of cellular-
ity and architectural features in the experimental groups and
may possibly be as a result of nicotine interactions on the
dopamine receptors seen in the substantia nigra. It has been
shown that chronic administration of nicotine facilitates re-
lease of dopamine and locomotor responses in rats. [45] A
previous study reported that nicotine acts on dopaminegic D1
and D2 receptors which invariably leads to up regulation of
the dopamine receptors, a condition described as dopamine
turnover. [45]
3.4 Quantitative changes in Substantia Nigra
Stereological techniques have often been used in describing
and quantifying neuronal count. [87] Terms such as many,
few, numerous are inappropriate in describing hypoplastic and
hyperplastic tissue changes but provides basis for hypothetical
testing in neuronal quantification. [88]
Pigmented neuron showed a dose dependant significant
increase in cell count as compared to the control group. This
significant increase was very transient and rapid in the group
that received the highest dose for seven days. This observation
confirmed the mild hyperplasic effect exerted by nicotine in
substantia nigra histology. The cell diameter showed a similar
increase (P > 0.05) which also indicated increase pigmenta-
tion in the neuron. These findings therefore, could be linked
to the stimulating effect of dopamine by nicotine as previously
reported. [3, 19] Reasons for a no significant finding could
be that a fraction of the drug which remained unchanged af-
ter metabolism and renal clearance was not potent enough to
cause a significant effect.
The current study evaluated the dose dependent increase
in neuronal count of the pigmented neurons exposed to nico-
tine for twenty one days which revealed significant increase in
pigmented cell number across the groups. This finding has crit-
ically explained the reasons for the observed increase in cellu-
larity as documented in the histology and further reinforces
the hypothesis that nicotine exerted a significant moderate hy-
perplastic effect on the substantia nigra. On cell dimensions,
neuron thickness revealed a physiologic hypertrophy which
was also not significant. Possible reasons for this could be
similar to that observed in day seven experimental animals
and could be attributed to the synaptogenic effect of nicotine
as has particularly been reported, where it facilitated forma-
tion of synapse and action potential by opening of calcium
channels. [89, 90] For further studies, studies should evaluate
brain nicotine receptor response on administration of nicotine
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using electroencephalogram.
Experimental animals administered nicotine for forty two
days showed extensive severe hyperplasia which corresponded
to the severe hyperplastic changes documented in the histol-
ogy of substantia nigra in day 42 rats. Severe hypertrophy
was also demonstrated in the cell diameter which was caused
by increased nicotinic receptor surge in the cell thickness and
also an increase in neuromelanin pigmentation in substantia
nigra neurons. This finding therefore ascertained the fact that
chronic administration of nicotine induced stimulation and
production of dopamine pigmentation which caused them to
fire rapidly as documented by Min et al. in 2004. [41] This
notable change could be ascribed to the fact that neuromelanin
which causes pigmentation in the substantia nigra neurons has
been reported to sequester chemicals. [91] More so, these
findings concurs with that of Sabine et al. (2004), [45] who
observed no morphological changes on but rather an induced
prolonged excitation of dopaminergic neurons on nicotine
administration
Likely mechanism of action of nicotine on substantia ni-
gra is that; the substantia nigra pars compacta is made up
of dopaminergic and cholinergic neurons which contain neu-
romelanin pigment granules while the ventral pars recticularis
contains fewer neurons grouped in clusters some of which
are dopaminergic while a major of them are gabaergic. [78]
Nicotine agonist has been shown to interact with these recep-
tors as noted by Min and his colleagues, who demonstrated
that nicotine effects are mediated by activation of nAChRs
located both postsynaptically and presynaptically. [44] A co-
hort Study also demonstrated physiologically that nicotine
levels in the brain enhanced excitatory glutaminergic inputs to
ventral tegmental dopamine neurons by activating presynaptic
α7 nAchRs. [42] A similar study also explained that it was
known to modulate inhibitory inputs by activating non α7
nAchRs seen in GABAergic cells, which decreases inhibition
to postsynaptic dopaminergic neurons. [43]
Nicotine has been related in the management of parkin-
sonism which has been reported to be seen in conditions that
share damage to dopaminergic neurons [68]. It is a clinical
movement disorder characterized by diminished facial ex-
pression, stooped posture, slowness of voluntary movement,
festinating gait and tremor. [68] Damage to about 80% of
dopaminergic neuron is a defect in parkinsonism. [85] The
present study showed no percentage of neuronal damage on
administration of nicotine and therefore implies that nicotine
can be used in the management of Parkinson disease (PD). A
study showed patients who smoke, are 50% less likely to have
PD when compared to their non-smoking counterparts. [92]
This however, suggests that nicotine a content of cigarette and
tobacco might exert a neuroprotective effect against degener-
ation and thereby preventing PD. This observation concurs
with similar studies which stated nicotine simulates dopamine
release and thereby suppresses early signs of PD. [92, 93]
3.5 Histological changes in hippocampus
Nicotine has been reported to elicit improvements in cognitive
function. [94] These effects may be related to stimulation of
neurotransmitter systems within areas of the brain that are
important for cognitive processing such as the hippocampus.
[95] Nicotine has also been reported to enhance learning and
memory in experimental animals which has also been related
to increased neural cell genesis in the dentate gyrus of the
brain hippocampal formation. [49]
The result of the present study indicates that sub-acute
administration of nicotine (animals administered 2mg/kg of
body weight nicotine) for seven days showed increased num-
ber of pyramidal and granular neurons which was elevated
and evident. This finding was in accordance with a study
by Carlson et al. (2000), who demonstrated that model ani-
mals administered low dose of nicotine at 1.70mg/kg nicotine
treated for 5 days produced no neuronal degenerative changes.
[96] Reasons for similarity in these two findings could be as-
cribed to the similarity in the dose, route and duration of drug
administration in the present study and the study of Carlson
et al. (2000).
The administration of nicotine to rats for twenty one
(2mg/kg; 4mg/kg; 6mg/kg) days showed increased cellularity
of the hippocampal neurons with maintained cytoarchitectural
and histoarchitectural features in the dentate gyrus and cornus
ammonis. This result further revealed that nicotine preserved
tissue stroma by attenuating neurodegeneration which was
seen in glial cells response to nicotine in the brain. In addition,
the resultant pattern also provided and agrees with studies that
revealed acute administration of nicotine will invariably lead
to neuroprotection as has been previously documented. [27,
97]
Higher doses of nicotine have previously been shown to
produce selective degeneration in the brain. [54] The cur-
rent study displayed a dose and time dependant progressive
increase in neuronal population which suggests severe hyper-
plasia. However, this study also demonstrated that chronic
administration of nicotine led to increase cell proliferation
rather than neurodegeneration as noted by Adeniyi and Musa
(2011), Ijomone et al. (2015). [50, 53] Possible reasons for
the dissimilarity could be attributed to difference in mode of
nicotine administration. In the current study, nicotine was
administered orally which implied it was actively metabo-
lized in the liver causing an unchanged fraction of the drug
to pose a significant effect. Furthermore, Ijomone et al. in
2015, used the subcutaneous route which implied that nicotine
had a slower absorptive rate as compared to the oral route of
drug administration. [53] For further studies as regards to this
study, electron microscopy is advised as it investigates the
ultrastructure of tissues.
3.6 Quantitative analysis of the effect of nicotine in
hippocampus
Stereological study showed that the pyramidal and granular
neurons cell count had a significant cell population with in-
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crease cellularity. The cell diameter showed large cell bodies
with increased nuclear size of pyramidal cells. This change
also suggests mild hyperplasia and hypertrophy as was already
demonstrated in the histomorphology of rats’ hippocampus
administered nicotine for seven days. Adeniyi and Ogundele
in 2014, reported decrease in pyramidal cell layer and granular
cell layers on administration of nicotine. [98] Possible reasons
for the differences may be due to differences in stereological
techniques used. The current study employed the use of the
dissector principle which involved the use of counting frames
compared to the technique adopted by Adeniyi and Ogun-
dele who measured cell thickness with a method described by
World Health Organization in 1991. [87] A more recent stere-
ological principle such as the fractionator principle should
be applied in further studies due to its varying range of cell
estimation
The pyramidal and granular layers of animals adminis-
tered nicotine for 21 days, showed a transient elevation in
cell count which was very apparent down the group. This
hypothesis further buttresses the fact that acute administration
of nicotine, lead to moderate hyperplasia and hypertrophy as
previously documented and is in accordance with a work by
Adeniyi and Musa in 2011 who concluded that nicotine admin-
istration caused hyperplasia in the hippocampus and that of
Ijomone et al. (2015), who reported hippocampal hypoplasia.
[50, 53] The reason for this is likely the time of administration
of nicotine. In the index study, different doses of nicotine was
administered 12 hours daily this was to maintain a steady and
continuous concentration of nicotine in blood circulation as
compared to Ijomone et al. (2015), who only administered
nicotine once daily. [53]
Hippocampal neuronal cell count of animals administered
nicotine for 42 days showed a significant increase in cellular-
ity of pyramidal, granular neuron and pyramidal cell thickness.
This contradicts the fact that long chronic exposure of nico-
tine causes memory deficits and unconsciousness. Possible
reasons for this finding could be attributed to the drug receptor
interaction between nicotine and α7nAChRs that resides in
the hippocampus. Nicotine has been shown to act on hip-
pocampal α7nAChRs which has been strongly evaluated in
learning and memory, [99] and also hippocampal α7 nicotinic
receptors have been confirmed to be a viable therapeutic tar-
gets. [100] However, further studies should investigate the
interaction between nicotine and hippocampal receptors with
the use electroencephalogram.
Findings from this study are imperative in the manage-
ment of Alzheimer’s disease (AD). AD is the major causative
factor for dementia and it becomes apparent with alterations
in mood and behavior, progressive disorientation, memory
loss and aphasia which indicate severe cortical dysfunction
associated with hippocampal degeneration. [68] Evidence has
suggested that accumulation of a peptide (β amyloid) in the
brain initiates a chain of events that results in morphologi-
cal changes in Alzheimer disease. This study recorded an
increase proliferation of pyramidal and granular neuron and
as such agrees to the assertionthat nicotine is putative in the
treatment of the cognitive function experienced by patients
with conditions such as AD. [101] Mechanism for this has
been demonstrated in both in-vivo and in-vitro studies where
nicotine increased the number of nAChRs to attenuate the cog-
nitive deficits found in AD associated with a decrease in the
level of acetylcholine due to degeneration of cholinergic neu-
rons. [102, 103] Findings from this study also demonstrated
increased and abundance of oligodendrocytes (Gliosis). Glio-
sis has been described as a nonspecific reactive change of
glial cells in response to damage to the central nervous system.
[104]
4. Conclusion
Sub-acute, acute and chronic administration of nicotine showed
mild, moderate and severe hyperplasia which was further es-
tablished by quantitative analysis.Hypertrophy in cell diame-
ters in three key regions of the brain; cerebellum, substantia
nigra and hippocampus was also observed. These features
were probably enhanced by the drug receptor interaction of
nicotine with nAChRs in brain tissue.
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